Tirzepatide (Mounjaro) – Diabetes & Weight Loss

What is Tirzepatide?

Tirzepatide, sold as Mounjaro, is an injectable medication that mimics two gut hormones (GLP-1 and GIP) to improve insulin response, lower blood sugar, and promote weight loss. It is approved for type 2 diabetes management and is being studied for obesity treatment.

Benefits of Tirzepatide (Mounjaro)

• Improves blood sugar control: Lowers A1C and fasting glucose levels.
• Promotes weight loss: Helps reduce appetite and food intake.
• Reduces cardiovascular risk: Supports heart health in diabetic patients.
• Once-weekly injection: Convenient dosing for long-term management.

Tirzepatide is administered subcutaneously once a week and works best alongside a healthy diet and exercise plan.